scholarly article | Q13442814 |
P356 | DOI | 10.1182/BLOOD.V98.12.3413 |
P698 | PubMed publication ID | 11719382 |
P2093 | author name string | Liu H | |
Siebert R | |||
Schlegelberger B | |||
Steinemann D | |||
Dyer MJ | |||
Willis TG | |||
Gesk S | |||
Harder L | |||
Oscier DG | |||
Satterwhite E | |||
Sonoki T | |||
Tucker PW | |||
Nowak R | |||
Price HP | |||
Arriola EL | |||
P2860 | cites work | Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3413-3420 | |
P577 | publication date | 2001-12-01 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | The BCL11 gene family: involvement of BCL11A in lymphoid malignancies | |
P478 | volume | 98 |
Q41083450 | A Compendium of Chromatin Contact Maps Reveals Spatially Active Regions in the Human Genome. |
Q35946229 | A Numerically Subdominant CD8 T Cell Response to Matrix Protein of Respiratory Syncytial Virus Controls Infection with Limited Immunopathology |
Q37644812 | A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis. |
Q60345371 | A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation |
Q35739462 | A global analysis of the complex landscape of isoforms and regulatory networks of p63 in human cells and tissues. |
Q29615157 | A highly efficient recombineering-based method for generating conditional knockout mutations |
Q34315758 | A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene. |
Q37081986 | A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene |
Q37327614 | A signature motif mediating selective interactions of BCL11A with the NR2E/F subfamily of orphan nuclear receptors. |
Q33569262 | A survey of well conserved families of C2H2 zinc-finger genes in Daphnia |
Q36110400 | A unique cytogenetic abnormality, t(2;7)(p13.1;p21.3), in a Philadelphia-positive chronic myeloid leukemia |
Q46215182 | AML1/RUNX1 gene point mutations in childhood myeloid malignancies |
Q37708916 | Aberrant localization of apoptosis protease activating factor-1 in lipid raft sub-domains of diffuse large B cell lymphomas. |
Q40660936 | Activation of HOX11L2 by juxtaposition with 3'-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2). |
Q42630118 | Activation-induced cytidine deaminase induces reproducible DNA breaks at many non-Ig Loci in activated B cells |
Q38347126 | Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair |
Q35349869 | An integrated cell purification and genomics strategy reveals multiple regulators of pancreas development |
Q40689379 | An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein-Barr virus-positive Hodgkin's lymphoma-derived cell line L591. |
Q45973697 | Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas. |
Q41808692 | Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas |
Q35622991 | B lymphoid neoplasms of mice: characteristics of naturally occurring and engineered diseases and relationships to human disorders |
Q37152985 | BCL11A Haploinsufficiency Causes an Intellectual Disability Syndrome and Dysregulates Transcription |
Q97066987 | BCL11A Is Oncogenic and Predicts Poor Outcomes in Natural Killer/T-Cell Lymphoma |
Q91713543 | BCL11A Promotes the Progression of Laryngeal Squamous Cell Carcinoma |
Q90698092 | BCL11A confers cell invasion and migration in androgen receptor-positive triple-negative breast cancer |
Q64054082 | BCL11A enhances stemness and promotes progression by activating Wnt/β-catenin signaling in breast cancer |
Q36964364 | BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification. |
Q24650585 | BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression |
Q34441819 | BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter |
Q93164819 | Bcl11 Transcription Factors Regulate Cortical Development and Function |
Q73451255 | Bcl11: sibling rivalry in lymphoid development |
Q24315994 | Bcl11A/CTIP1 regulates expression of DCC and MAP1b in control of axon branching and dendrite outgrowth |
Q41363689 | Bcl11a Deficiency Leads to Hematopoietic Stem Cell Defects with an Aging-like Phenotype |
Q34760844 | Bcl11a controls Flt3 expression in early hematopoietic progenitors and is required for pDC development in vivo |
Q36478284 | Bcl11a is essential for lymphoid development and negatively regulates p53. |
Q28511014 | Bcl11a is essential for normal lymphoid development |
Q28592191 | Bcl11b is required for differentiation and survival of αβ T lymphocytes |
Q33302970 | Bcl11b mutations identified in murine lymphomas increase the proliferation rate of hematopoietic progenitor cells |
Q48447959 | Bcl11b prevents the intrathymic development of innate CD8 T cells in a cell intrinsic manner. |
Q38692964 | Bcl11b-A Critical Neurodevelopmental Transcription Factor-Roles in Health and Disease. |
Q33361902 | Bcl11b: A New Piece to the Complex Puzzle of Amyotrophic Lateral Sclerosis Neuropathogenesis? |
Q24534913 | COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein |
Q33642286 | CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis |
Q30862469 | CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status |
Q34148512 | Cancer biology and NuRD: a multifaceted chromatin remodelling complex |
Q54608168 | Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia. |
Q53620559 | Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma. |
Q58001012 | Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis |
Q33437080 | Chronic Lymphocytic Leukemia with Translocation (2;14)(p16;q32): A Case Report and Review of the Literature |
Q35742367 | Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries. |
Q92646611 | Clinical significance of BCL11A expression in ER-negative and PR-negative endometrial carcinoma |
Q33864314 | Combination of BCL11A siRNA with vincristine increases the apoptosis of SUDHL6 cells |
Q39105585 | Comparative analysis of hepatocellular carcinoma and cirrhosis gene expression profiles |
Q33935974 | Contingent gene regulatory networks and B cell fate specification |
Q47290416 | Corrected and Republished from: BCL11A Is a Critical Component of a Transcriptional Network That Activates RAG Expression and V(D)J Recombination |
Q27319539 | Ctip1 Regulates the Balance between Specification of Distinct Projection Neuron Subtypes in Deep Cortical Layers |
Q35213318 | Cytogenetic evolution of follicular lymphoma |
Q91680524 | DNA methylation profiling implicates exposure to PCBs in the pathogenesis of B-cell chronic lymphocytic leukemia |
Q36800496 | DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease |
Q41921064 | De novo 2p16.1 microdeletion with metastatic esophageal adenocarcinoma |
Q37659927 | Dendritic cell fate is determined by BCL11A. |
Q28273746 | Deregulation of the carbohydrate (chondroitin 4) sulfotransferase 11 (CHST11) gene in a B-cell chronic lymphocytic leukemia with a t(12;14)(q23;q32) |
Q34387780 | Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. |
Q37641982 | Downregulation of BCL11A by siRNA induces apoptosis in B lymphoma cell lines |
Q47409251 | Enforced expression of MIR142, a target of chromosome translocation in human B-cell tumors, results in B-cell depletion |
Q92052916 | Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia |
Q64933372 | Epsilon-Globin HBE1 Enhances Radiotherapy Resistance by Down-Regulating BCL11A in Colorectal Cancer Cells. |
Q40537994 | Epstein-Barr virus is integrated between REL and BCL-11A in American Burkitt lymphoma cell line (NAB-2). |
Q30478328 | Expression of the brain transcription factor OTX1 occurs in a subset of normal germinal-center B cells and in aggressive Non-Hodgkin Lymphoma |
Q35909440 | Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity |
Q58700685 | Functional characterization of TBR1 variants in neurodevelopmental disorder |
Q21093284 | Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells |
Q55042257 | Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma. |
Q61312181 | Gains ofREL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein |
Q45012890 | Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs |
Q38973429 | Gene expression profile analysis of SUDHL6 cells with siRNA-mediated BCL11A downregulation |
Q35041552 | Gene expression profiles in BCL11B-siRNA treated malignant T cells |
Q39630988 | Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion. |
Q36287371 | Genetic polymorphisms and plasma levels of BCL11A contribute to the development of laryngeal squamous cell carcinoma |
Q37622580 | Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer |
Q24652468 | Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia |
Q93182953 | Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016 |
Q36513564 | Genomic alterations in Hodgkin's lymphoma |
Q26822390 | HEB in the spotlight: Transcriptional regulation of T-cell specification, commitment, and developmental plasticity |
Q33361527 | Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin |
Q37298691 | High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia |
Q34161181 | High incidence of Hox11L2 expression in children with T-ALL. |
Q38486378 | Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2. |
Q28508746 | Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas |
Q60921425 | Identification of key genes and specific pathways potentially involved in androgen-independent, mitoxantrone-resistant prostate cancer |
Q48315981 | Identification of novel BCL11A variants in patients with epileptic encephalopathy: Expanding the phenotypic spectrum. |
Q47824801 | Identification of novel mutations in the HbF repressor gene BCL11A in patients with autism and intelligence disabilities. |
Q38441009 | Identification of proteins from formalin-fixed paraffin-embedded cells by LC-MS/MS. |
Q36824956 | Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature |
Q34463668 | Induction of adult levels of β-globin in human erythroid cells that intrinsically express embryonic or fetal globin by transduction with KLF1 and BCL11A-XL |
Q54342522 | Influences of genetic variation on fetal hemoglobin. |
Q61312332 | Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci |
Q24650557 | Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression |
Q34609906 | Lack of Bcl11b tumor suppressor results in vulnerability to DNA replication stress and damages |
Q34126438 | Lack of somatic hypermutation of IG V(H) genes in lymphoid malignancies with t(2;14)(p13;q32) translocation involving the BCL11A gene |
Q34469099 | Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients |
Q34055169 | MiR-3960 binding sites with mRNA of human genes |
Q34673170 | MicroRNA-486-3p regulates γ-globin expression in human erythroid cells by directly modulating BCL11A. |
Q38484538 | Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci |
Q91940302 | Molecular simulation studies on B-cell lymphoma/leukaemia 11A (BCL11A) |
Q36224328 | Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells. |
Q36579119 | Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study |
Q49513753 | Predictors of lymphovascular invasion identified from pathological factors in Chinese patients with breast cancer |
Q37015302 | Protein Kinase C-Mediated Phosphorylation of BCL11B at Serine 2 Negatively Regulates Its Interaction with NuRD Complexes during CD4+ T-Cell Activation |
Q34342958 | Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. |
Q33244998 | Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications |
Q83995851 | REL-positive double minute chromosomes in follicular lymphoma |
Q36759660 | RETRACTED: The BCL11A transcription factor directly activates RAG gene expression and V(D)J recombination |
Q80890208 | Rapid amplification of immunoglobulin heavy chain switch (IGHS) translocation breakpoints using long-distance inverse PCR |
Q34576134 | Reduced level of the BCL11B protein is associated with adult T-cell leukemia/lymphoma |
Q39323710 | Regulation of prostate cancer immunity-related genes in PC3 prostate cancer cells by ETS-1 |
Q80731905 | Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, deltaTrkA |
Q35094507 | Retroviral insertional mutagenesis: tagging cancer pathways |
Q27014084 | Role of the transcription factor Bcl11b in development and lymphomagenesis |
Q49910540 | SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia |
Q36605667 | Somatic stem cells and the origin of cancer |
Q40529812 | Spontaneously immortalized human T lymphocytes develop gain of chromosomal region 2p13-24 as an early and common genetic event. |
Q90439002 | Structure of SWI/SNF chromatin remodeller RSC bound to a nucleosome |
Q48726361 | Systematic tracking of dysregulated modules identifies novel genes in cancer |
Q36138285 | The BCL11A-XL expression predicts relapse in squamous cell carcinoma and large cell carcinoma |
Q57447372 | The BCL11AXL transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells |
Q91658641 | The Unsolved Puzzle of c-Rel in B Cell Lymphoma |
Q101403190 | The bone marrow microenvironment of pre-B acute lymphoblastic leukemia at single-cell resolution |
Q28241767 | The c-Rel transcription factor and B-cell proliferation: a deal with the devil |
Q34662848 | The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia |
Q50201177 | The expression pattern of Bcl11a, Mdm2 and Pten genes in B-cell acute lymphoblastic leukemia. |
Q24294822 | The functional interactome landscape of the human histone deacetylase family |
Q42944687 | The gene expression patterns of BMPR2, EP300, TGFβ2, and TNFAIP3 in B-Lymphoma cells |
Q91723487 | The global clonal complexity of the murine blood system declines throughout life and after serial transplantation |
Q35140188 | The pathogenetic role of oncogenes deregulated by chromosomal translocation in B-cell malignancies. |
Q36444458 | The role of BCL11B in hematological malignancy |
Q64246815 | The rs61742690 (S783N) single nucleotide polymorphism is a suitable target for disrupting BCL11A-mediated foetal-to-adult globin switching |
Q33301651 | Three-dimensional culturing of the Hodgkin lymphoma cell-line L1236 induces a HL tissue-like gene expression pattern |
Q35610677 | Transcriptional Dynamics of Immortalized Human Mesenchymal Stem Cells during Transformation. |
Q27011507 | Using mouse models to study function of transcriptional factors in T cell development |
Q27015808 | Vitamin D and microRNAs in bone |
Q73826929 | [Genetic changes in chronic lymphocytic leukemia] |
Q34163536 | p53-Dependent transcriptional responses to interleukin-3 signaling |
Search more.